Nov 5 (Reuters) - (All figures in US Dollars)
Genmab A/S GMAB.CO reports its third quarter results on November 6.
Year to date, Genmab A/S shares are up 24.92%.
Below is a table of quarterly and annual analyst estimates for results based on LSEG data.
Qtr. to September 2025
No. of analysts
Mean Estimate
Revenue
10
991.17 million
Pre-tax profit
6
377.94 million
EPS
8
4.64
EBIT
8
379.51 million
Net Profit
7
297.86 million
Year to December 2025
No. of Analysts
Mean Estimate
Revenue
18
3.66 billion
Pre-tax profit
15
1.36 billion
EPS
16
16.94
EBITDA
13
1.38 billion
EBIT
16
1.24 billion
Net Profit
16
1.07 billion
Dividend
12
0.00
Net Debt
10
-3.13 billion
Genmab A/S belongs to the OMX Copenhagen 20 Index. Please note that consensus estimates may be updated between publication of the poll and the report.
This summary was auto generated on November 4 at 15:32.
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com, +48 58 7696600))
